RAMO News Alert Ramoil Management Ltd (RAMO) 0.0034 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ramoil Management Ltd (RAMO) 0.0034 $RAMO

Ramoil Management, Ltd. Signs An Agreement To Begin In Michigan
PR Newswire - Mon Dec 01, 7:45AM CST
RAMOIL MANAGEMENT, Ltd. (OTCPink: RAMO) announces that RAMO Bio-Med, Inc., its wholly owned subsidiary, has signed a Binding LOI / Agreement with a licensed, legal and "unnamed" Michigan Cannabis Group to begin setting up facilities throughout Michigan, starting in the city of Flint.

RAMOIL MANAGEMENT, Ltd Begins Sales Of Its Proprietary "RAMO CBD Pain" And THC Formulated Product Lines
PR Newswire - Tue Nov 18, 7:45AM CST
RAMOIL MANAGEMENT, Ltd (OTCPink: RAMO) announces that RAMO Bio-Med, Inc., its wholly owned subsidiary, has now completed the R&D, printing and packaging and has begun the initial product rollout of "RAMO CBD Pain" product line, utilizing our own proprietary formulas and proprietary High CBD, Extremely Low THC Cannabis Strain, through Natural Elements Group, Inc. in California. Further, RAMO Bio-Med, Inc. also consulted with Natural Elements Group, Inc. to formulate their own THC product line as well.

Ramoil Management, Ltd Honors Our Veterans With The Beginning Of PTSD Formula(s) Testing
PR Newswire - Wed Nov 12, 7:45AM CST
RAMOIL MANAGEMENT, Ltd (OTCPink: RAMO) wants to honor and support our veterans by announcing that RAMO Bio-Med, Inc., its wholly owned subsidiary, is beginning with controlled clinical testing of "RAMO CBD" and "RAMO THC" formulas for the treatment of Post Traumatic Stress Disorder, commonly known as PTSD.

Ramoil Management, Ltd. Announces Completion Of Its Proprietary "RAMO CBD Pain" Product Line
PR Newswire - Mon Nov 10, 7:45AM CST
RAMOIL MANAGEMENT, Ltd. (OTCPink: RAMO) announces that RAMO Bio-Med, Inc., its wholly owned subsidiary, has finalized the R&D and product development of the first "RAMO CBD Pain" product line, utilizing our own proprietary formulas and proprietary High CBD, Extremely Low THC Cannabis Strain.

RAMOIL MANAGEMENT, Ltd Announces Update Regarding Nevada License
PR Newswire - Thu Nov 06, 7:45AM CST
RAMOIL MANAGEMENT, Ltd (OTCPink: RAMO) announced that it has been contacted by "Player's Network, Inc." CEO, Mark Bradley and their Vice President and Attorney, Michael Pratter and informed that our application, submitted to the City of North Las Vegas, for a cultivation license and processing license, has been approved and sent on to the State of Nevada for finalizing.

Ramoil Management, Ltd to OEM its Own Supercritical Co2 Extraction Line of Equipment
ACCESSWIRE - Mon Oct 27, 8:12AM CDT
LAS VEGAS, NV / ACCESSWIRE / Ocotber 27, 2014 / RAMOIL MANAGEMENT, Ltd (OTC Pink: RAMO) (PINKSHEETS: RAMO), announced that it is close to completing negotiation and an agreement with the top "OEM Equipment Manufacturer", in this sector, to launch it's own proprietary line of "Supercritical CO2 Molecular Extraction Equipment" under the "RAMO" brand name.

Ramoil Management, Ltd Retires All Long-Term Debt and Commences With First Revenues
Marketwired - Wed Oct 22, 8:04AM CDT
Ramoil Management, Ltd (PINKSHEETS: RAMO) announced that it has retired all long-term debt, dating back to and including 2008, in the 2nd Quarter and commences with much anticipated revenues in the 3rd Quarter.

Ramoil Management, Ltd Creates Proprietary CBD Formula to Aid West Nile Virus Patient in Southern California
ACCESSWIRE - Mon Oct 20, 8:03AM CDT
LAS VEGAS, NV / ACCEWIRESS / October 20, 2014 / RAMOIL MANAGEMENT, Ltd (OTC Pink: RAMO) (PINKSHEETS: RAMO), announced that its wholly owned subsidiary, RAMO Bio-Med, Inc., has created a proprietary high CBD, extremely low THC formula to aid a Southern California victim of West Nile Virus.

RAMO Bio-Med, Inc. Commences With Research on Charlottes Web or AC/DC Cultivation and Genetic Molecular Engineering
ACCESSWIRE - Thu Oct 02, 11:08AM CDT
Image: https://www.baystreet.ca/uploads/ramo-logo.png

Ramoil Meeting With Potential Facility Partners in Multiple States and Countries
ACCESSWIRE - Thu Sep 25, 8:05AM CDT
LAS VEGAS, NV / ACCESSWIRE / September 25, 2014 / RAMOIL MANAGEMENT, Ltd, (OTC Pink: RAMO) (PINKSHEETS: RAMO), would like to announce that it has begun to meet with and evaluate potential funding partners in multiple states, including California, Arizona, Nevada and Florida. In addition to this, RAMO Bio-Med, Inc. has opened conversations with potential international funding partners in Canada and Europe.

Ramoil Management, Ltd: Updates and New 2-11 Filing in Process
ACCESSWIRE - Mon Sep 22, 8:03AM CDT
LAS VEGAS, NV / ACCESSWIRE / September 22, 2014 / RAMOIL MANAGEMENT, Ltd, (OTC Pink: RAMO) (PINKSHEETS: RAMO), would like to announce that it has begun the update process, including preparing for the filing of a "Form 2-11", through a Market Maker, with FINRA.

Marijuana Extraction Compound May Slow or Even Halt the Progression of Alzheimer's
ACCESSWIRE - Mon Sep 08, 9:38AM CDT
LAS VEGAS, NV / ACCESSWIRE / September 8, 2014 / RAMOIL MANAGEMENT, Ltd (OTC Pink: RAMO) (PINKSHEETS) would like to share the following findings with its shareholders and prospective shareholders, as "High CBD and Extremely Low THC Extraction" is exactly what RAMO Bio-Med, Inc., our wholly owned subsidiary, respectively does and can do:




Scroll down for more posts ▼

Top 10 Most Recent News Articles

IBM's Sports Tech Challenge Crowns AI Innovator LivXP

Updated Category News Views 18

Pioneering AI for Fan Engagement The big leagues of sports tech are buzzing, as IBM has just announced LivXP as the standout winner of their Sports Tech Startup Prize Challenge at the dynamic Web Summit Lisbon 2026. If there's one thing to remember, it's that this isn't just any accolade. This is a nod from IBM—an institution that's rubbed elbows with the giants of...

Continue Reading
Skilled Nursing: The Backbone of Comprehensive Care

Updated Category News Views 17

Crucial Crossroads: Hospital to Home Some stories don't come with ticker symbols or stock rises. Sometimes, we're sifting through what really matters—like Terry Esterline's rundown on skilled nursing and rehab services in Hillsdale, Michigan. This isn't about making a quick buck, it's about what helps people rebuild after a hospital stay. The Nuts and Bolts of Skilled...

Continue Reading
Nauticus Schedules 2026 Q3 Earnings Call; Key Insights Await

Updated Category News Views 100

Word on the street is that Nauticus Robotics is gearing up to dish out their third quarter earnings on November 17, 2026. If you're eyeballing the stock, NASDAQ:KITT, this might be your show. Autonomy in the subsea world isn't just about flashy tech—it's about getting investors to buy into the vision. These folks are turning waves into action with robots that perform...

Continue Reading
HLTH 2026: AI's Role in Couples Therapy Unveiled

Updated Category News Views 14

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Continue Reading
DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 266

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Baidu Faces Securities Suit Deadline This Week

Updated Category News Views 74

Deadline Looms Large for Baidu Investors Well, here we are again, dealing with another securities class action. If you've got your money parked in Baidu (NASDAQ:BIDU), the clock is ticking, and it's time to pay attention. November 13, 2026, is creeping up fast, and that could be a serious point of no return. What's the Buzz About? Faruqi & Faruqi, LLP, a heavyweight in...

Continue Reading
FIS Under Investigation: Legal Woes Hit Shareholders

Updated Category News Views 55

When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...

Continue Reading
Millrose Faces Class Action for Alleged Deception

Updated Category News Views 124

A Surprising Turn for Millrose Properties Nobody's grumbling over their coffee as much as Millrose Properties' investors these days. The company, traded under NYSE:MRP, is facing a securities class action lawsuit that'll make even the steeliest fund managers flinch. You see, this isn't just any lawsuit—it's a slap in the face of those who thought they were backing a...

Continue Reading
Frasle Mobility's Resilience Despite Market Woes in 3Q26

Updated Category News Views 125

Economic Wrangling: What Happened? Here comes Frasle Mobility, standing tall against a tide trying to pull everyone under. Ending the third quarter of 2026, they dropped a modest net revenue of R$1.38 billion. A light dip of 1.9% year-over-year, but don't let that fool you. Amid the chaos, these folks managed to expand their gross margin and kept their financials...

Continue Reading
MY DR NOW Challenges 9-to-5 with New Clinics

Updated Category News Views 12

Revolutionizing Healthcare Access Latte in one hand and the other hand tapping your steering wheel, trying to squeeze in that elusive doctor’s appointment between work meetings. Sound familiar? Well, those days might just be numbered. MY DR NOW is shaking up the traditional 9-to-5 doctor’s office stereotype by opening two new clinics that’ll stand sentinel seven...

Continue Reading

Top 5 Most Recently Viewed Articles

Immunocore Unveils Promising Data for Brenetafusp in Ovarian Cancer

Updated Category News Views 129

Immunocore Takes Key Steps with Brenetafusp Immunocore, a biotechnology firm dedicated to creating innovative immunomodulating treatments, has revealed important findings from the Phase 1 trials of brenetafusp, an ImmTAC bispecific that targets PRAME in ovarian cancer patients who are resistant to platinum therapy. These results were shared at a notable medical...

Continue Reading
Santhera and Ikris Pharma Join Forces for AGAMREE® in India

Updated Category News Views 216

Santhera Partners with Ikris for AGAMREE® Distribution Pratteln, Switzerland – Santhera Pharmaceuticals (SIX: SANN) has recently formed a pivotal agreement with Ikris Pharma Network to distribute AGAMREE® (vamorolone) in India. This exclusive partnership is dedicated to providing a treatment option for Duchenne muscular dystrophy (DMD) in children four years and...

Continue Reading
Orchid Island Capital Highlights August Dividend and Portfolio Insights

Updated Category News Views 183

Orchid Island Capital Declares August Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC), a prominent player in the specialized finance sector, has declared a monthly cash dividend of $0.12 per common share for August. This dividend is scheduled for distribution on September 29, keeping with the company’s commitment to returning value to its shareholders. Dividend...

Continue Reading
Mercari Japan App Debuts in U.S.: A Shopping Shift

Updated Category News Views 15

A New Frontier for Cross-Border Shopping There's a fresh wind blowing for collectors and Japan enthusiasts in the U.S. as Mercari Japan rolls out a new standalone app on American soil. Designed to streamline the hunt for Japanese treasures, it’s a bold play to solidify Mercari’s position as a cross-border e-commerce powerhouse. Maybe they’ve seen the writing on the...

Continue Reading
Franklin Access Receives Financing for Groundbreaking Sigbeat Venture

Updated Category News Views 195

Franklin Access Secures New Funding for Innovative Sigbeat Joint Venture Franklin Access (NASDAQ: FKWL) is thrilled to announce that it has successfully secured funding for its strategic joint venture to develop cutting-edge 4G/5G modules and artificial intelligence (AI) solutions under the Sigbeat brand. This significant milestone marks a transformative step towards...

Continue Reading